Sanofi-Aventis (France) Plans $2.6 Billion Counterbid for Zentiva
PARIS, June 18 (Reuters) - French drugmaker Sanofi-Aventis plans to make a 40.04 billion crown ($2.57 billion) offer for Czech drugmaker Zentiva, trumping a bid from financial group PPF.